blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4031536

EP4031536 - IDENTIFICATION OF COMPOUNDS THAT INHIBIT STRESS GRANULE FORMATION AND TAU AGGREGATION BY TARGETING TIA1 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.07.2024
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  24.06.2022
FormerThe international publication has been made
Status updated on  26.03.2021
Most recent event   Tooltip19.07.2024Application deemed to be withdrawnpublished on 21.08.2024  [2024/34]
Applicant(s)For all designated states
The Trustees Of Columbia University In The City Of New York
535 West 116th Street
412 Low Memorial Library
New York, NY 10027 / US
[2022/30]
Inventor(s)01 / RAYMAN, Joseph, B.
530 W. 113th Street Apt. 2B
New York, NY 10025 / US
02 / LANDRY, Donald
c/o Columbia University
535 West 116th Street
412 Low Memorial Library
New York, NY 10027 / US
03 / DENG, Shixian
c/o Columbia University 650 W. 168th Street,
Bb1029
New York, NY 10032 / US
 [2022/30]
Representative(s)Berggren Oy
P.O. Box 16
Eteläinen Rautatiekatu 10A
00101 Helsinki / FI
[2022/30]
Application number, filing date20865295.816.09.2020
[2022/30]
WO2020US51107
Priority number, dateUS201962900784P16.09.2019         Original published format: US 201962900784 P
[2022/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021055502
Date:25.03.2021
Language:EN
[2021/12]
Type: A1 Application with search report 
No.:EP4031536
Date:27.07.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 25.03.2021 takes the place of the publication of the European patent application.
[2022/30]
Search report(s)International search report - published on:US25.03.2021
ClassificationIPC:C07D275/04, A61K31/428, A61P25/00, A61K35/00
[2022/30]
CPC:
A61K31/506 (EP,US); C07D275/04 (EP,US); A61K31/403 (EP);
A61K31/428 (EP,US); A61K31/437 (EP,US); A61K31/4412 (US);
A61K31/519 (EP,US); A61K31/5377 (US); A61K31/69 (US);
A61K45/06 (EP); A61P25/28 (EP); C07D513/04 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/30]
TitleGerman:IDENTIFIZIERUNG VON VERBINDUNGEN ZUR HEMMUNG DER BILDUNG VON STRESSGRANULATEN UND TAU-AGGREGATION DURCH DAS TARGETING VON TIA1[2022/30]
English:IDENTIFICATION OF COMPOUNDS THAT INHIBIT STRESS GRANULE FORMATION AND TAU AGGREGATION BY TARGETING TIA1[2022/30]
French:IDENTIFICATION DE COMPOSÉS INHIBANT LA FORMATION DE GRANULES DE STRESS ET L'AGRÉGATION DE PROTÉINES TAU PAR CIBLAGE DE TIA1[2022/30]
Entry into regional phase14.03.2022National basic fee paid 
14.03.2022Search fee paid 
14.03.2022Designation fee(s) paid 
14.03.2022Examination fee paid 
Examination procedure14.03.2022Examination requested  [2022/30]
03.04.2024Application deemed to be withdrawn, date of legal effect  [2024/34]
24.04.2024Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2024/34]
Fees paidRenewal fee
27.01.2023Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.09.202203   M06   Fee paid on   27.01.2023
30.09.202304   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2008005538  (EXELIXIS INC [US], et al) [X] 1-3 * para [0027], [00105]; pg 58, Table, Entry 519 *;
 [A]WO2011062864  (UNIV EMORY [US], et al) [A] 1-3 * pg 14, Table; pg 29, In 18 to pg 30, In 5; claims 12-13 *;
 [A]US2017044185  (MA HAICHING [US], et al) [A] 1-3 * para [0123], [0127] *;
 [X]WO2017066657  (AQUINNAH PHARMACEUTICALS INC [US], et al) [X] 1 * pg 2, para 1, para 5; pg 6, para 3 *;
 [A]WO2019030692  (FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RES [CH]) [A] 1-3* Entire Document *;
 [X]  - "2-(3,5-Dimethylphenyl)-1,2-benzothiazol-3-one", PUBCHEM Compound, (20071205), Database accession no. CID22416252, URL: ncbi, XP055808012 [X] 12 * pg 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.